CGTI Podcast Interview: Automating aseptic filling for lowest volumes

Precisely for CGT: automating aseptic filling for lowest volumes

“The question is: which primary packages are suitable for all process steps and unit operations, and flexible enough to be used from early development to scale-up?”

Find answers to the following questions:

• The number of approved cell and gene therapies is increasing. However, prices remain incredibly high – from several hundred thousand to millions of US dollars. What are the most important factors to consider when looking to make significant cost savings?
• What are the biggest hurdles that need to be overcome to address the issues of standardization and scale-up, and speed up this process?
• What specific trends are you seeing currently in the selection of primary packaging?
• What are the key challenges and limitations when using single-use bags in small volume manufacturing?
• What are your top recommendations for manufacturers who are transferring a process from manual to automized production?